COMPANY PROFILE

FUTURE CURE

Explore full profile

Developing cutting-edge technologies to diagnose & treat chronic diseases

IndiaFounded 2019Biotech & Life Sciences

Valuation $50–100M Last recorded · 2026

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

At a glance

Status: Operational
Founded: 2019
Headquarters: India
Employees: 3
Open positions: None listed
Dealroom signal: 54.8/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Chronic Disease, Biotech and Pharma, DT and LS, science-based
Business model: Manufacturing
Client focus: b2c
Links: Website LinkedIn

Founder mafia, market maps, research and news connected to this company by Dealroom

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES B✓Equity / VC	Jan 2026	$12M	$46M	Carnelian Asset Advisors	↗
SEED✓Equity / VC	Jan 2022	$4M	$16M	Unicorn India Ventures · Kotak Alternate Asset Managers	—

FUTURE CURE website traffic

Latest recorded traffic for FUTURE CURE is 240 monthly website visits, down 29.4% over the last three months.

Latest monthly visits240 3-month web change-29.4%

Monthly website visitsJan 2025–Feb 2026

Summary metrics are public; monthly history is available with a demoCompare with peers →

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
KPKind PharmaceuticalDeveloping small-molecule drugs for anemia and oncology	Hangzhou, China	Operational	—	$55M	$220M
CICue2Walk InternationalDeveloping medical devices and applying modern technology to keep people (with Parkinson's disease) active	The Hague, Netherlands	Operational
EPEpiendoDevelops drugs that target epithelial differentiation, regeneration, and barrier function	Reykjavík, Iceland	Operational
APAfferent PharmaceuticalsClinical-stage biopharmaceutical company that develops medicines to treat chronic pain	Boston, United States	Acquired
SPSpinifex PharmaceuticalsClinical-stage biotechnology company specializing in the development of products for the treatment of pain	Stamford, United States	Acquired
RERejuvenAirCSA Medical is a provider of innovative spray cryotherapy medical device solutions	Lexington, United States	Operational
RHRadius HealthGlobal biopharmaceutical company focused on addressing unmet medical needs in the area of bone health	Cambridge, United States	Acquired
HEHeadwayNon-Invasive Computerized Treatment Table for Chronic Headache and Neck Pain	Qiryat Ono, Israel	Operational